Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback